Artificial Heart Maker's Future Seen in Hands of Core Backers
Troubled artificial heart maker Carmat is appealing to key shareholders led by Airbus to invest new funds to avoid the collapse of the 30-year-old venture.
Stay updated with breaking news from Samir Devani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Troubled artificial heart maker Carmat is appealing to key shareholders led by Airbus to invest new funds to avoid the collapse of the 30-year-old venture.
Troubled artificial heart maker Carmat is appealing to key shareholders led by Airbus to invest new funds to avoid the collapse of the 30-year-old venture dating back to a chance meeting between...
By Michal Aleksandrowicz, Tim Hepher and Laura Lenkiewicz PARIS (Reuters) - Troubled artificial heart maker Carmat is appealing to key shareholders le...
Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript September 21, 2023 Valneva SE misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.36. Operator: Good day, and thank you for standing by. Welcome to the Valneva Half Year 2023 Financial Results Call and Webcast. [Operator Instructions] Please note that today’s conference is being […]
Operator: Good morning, and welcome to the BioXcel Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.